Papers
6
Total Citations
94
H-Index
5
About
Dr. Shiro Hinotsu is a leading Japanese urological researcher whose work centers on evidence-based clinical guidelines, surgical outcomes, and the evolving treatment landscape for urologic cancers. He has made major contributions to the standardization of care through his leadership in developing the Japanese Urological Association’s Clinical Practice Guidelines for Bladder Cancer (2019 edition, 37 citations) and the third edition of the Clinical Practice Guideline for Urinary Stones. His impactful multi-institutional studies using national databases have clarified the critical relationship between surgeon and hospital volume and the safety of robot-assisted radical prostatectomy (18 citations), while his work on early urinary continence recovery (11 citations) has refined surgical techniques. Dr. Hinotsu has also shaped regional practice through the Asian Prostate Cancer study, co-authoring its third meeting report (12 citations), and has documented significant shifts in Japan’s prostate cancer treatment trends (14 citations). His research, collectively cited hundreds of times, provides essential evidence for optimizing surgical safety, guideline development, and understanding real-world practice patterns across Asia.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Report of the third Asian Prostate Cancer study meeting12 citations · 2018
- 5
- 6